Mycoplasma Testing Market Size by Product and Service, Technology, Application, End-User, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032
Overview
Mycoplasma Testing Market size is expected to reach nearly USD 4.05 Bn by 2032 with the CAGR of 11.5% during the forecast period.
The Global Mycoplasma Testing Market report is a comprehensive analysis of the Technique, market, and key players. The report has covered the market by demand and supply-side by segments. The Mycoplasma Testing Market report also provides trends by market segments, technology, and investment with a competitive landscape.
To know about the Research Methodology :- Request Free Sample Report
Mycoplasma Testing Market Overview:
Mycoplasma testing is a group of tests that measure antibodies in the blood produced in reaction to a mycoplasma infection or detect the microbe directly through culturing or by detecting the genetic material (DNA or RNA) in a body sample. Mycoplasma Testing is widely used in the detection of Mycoplasma pneumonia.
Mycoplasma Testing Market Dynamics:
The global mycoplasma testing market was valued at USD 755.8million in 2025 and is anticipated to reach USD 4.05 Billion by 2032 at a CAGR of 11.5% in the forecast period of 2026-2032
The demand for the mycoplasma testing market is anticipated to grow in the forecast period due to growing investment in research and development and testing techniques. Moreover, growing life science is further boosting the market for mycoplasma testing. This is further fueled by growing concern about cell culture contamination. As cell culture is carried out in laboratories. And this can be chemical contamination or biological contamination. Chemical contamination can be coming from sera, media, water, endotoxins, plasticizers, and detergents. And biological contamination includes mold, yeast, bacteria, viruses, etc.
Additionally, the rising research and development in clinical trials with government authorization and regulatory affairs are creating more opportunities in the market. As research and development is focusing on reducing the cost of processing and testing kits and operating costs with easy patient recruitment are further boosting the demand of the mycoplasma testing market in the forecast period.
Mycoplasma Testing Market Segment Analysis:
By Product and Service, Assays, Kits, and Reagents dominated the product and services segment of the mycoplasma testing market in 2025. As testing kits are more preferred as they are used one time and then discarded. Also, this does not involve a huge cost investment. Moreover, testing kits are more used as compared to instruments.
By Technology, ELISA testing dominated the technique segment of the mycoplasma testing market in 2025. ELISA test stands for Enzyme-Linked Immunosorbent Test. This test is widely used in the detection of HIV infection. ELISA test is more accurate compared to the test like radioimmunoassay (RIA). Moreover over tests include benefits like quick and accurate results, high sensitivity, automation, ease of operation driving the market growth in the forecast period. Further ELISA test market is anticipated to grow with a CAGR of 7.45% in the forecast period.
By Application, Cell line testing dominated the application segment of the mycoplasma testing market in 2025. Due to rising demand for monoclonal antibodies and increasing biopharmaceutical industries globally. The test is performed for the detection of microsatellite regions of DNA that have variable numbers of repeats and are located throughout the genome.
By End-User, Biopharmaceutical dominated the end-user segment of the mycoplasma testing market in 2025. Mycoplasma testing is used in Vaccines, cell culture, manufacturing. Mycoplasma testing includes the group of testing that measure antibodies in the blood in response to mycoplasma infection. Moreover, biotechnology is boosting the innovation of various testing techniques for the detection of viruses and DNA mutation and this has further boosted the demand of the biopharmaceutical industry globally.
Mycoplasma Testing Market Regional Insights:
North America dominated the mycoplasma testing market of the regional segment in 2025 and accounts for the largest market share in the market. Also high adoption of the latest technologies in the region moreover the research studies in biopharmaceuticals is further boosting the market. The US spends 22% of total revenue in the pharmaceutical industry for research and development. Further, the US healthcare and pharmaceutical industry spends 8.34 million in digital advertisement to increase the awareness in consumers about the latest technologies and advanced testing. The rising healthcare industry together with huge investment in the research and development sector is further boosting the market of North America.
The objective of the report is to present a comprehensive analysis of the global Mycoplasma Testing Market to the stakeholders in the Technique. The past and current status of the Technique with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the Technique with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the Technique to the decision-makers.
The report also helps in understanding the global Mycoplasma Testing Market dynamics, structure by analyzing the market segments and project the global Mycoplasma Testing Market size. Clear representation of competitive analysis of key players by Product and Service price, financial position, Cetyl Myristoleate portfolio, growth strategies, and regional presence in the global Mycoplasma Testing Market make the report investor’s guide.
Mycoplasma Testing Market Scope: Inquire before buying
| Global Mycoplasma Testing Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 1.89 USD Billion |
| Forecast Period 2026-2032 CAGR: | 11.5% | Market Size in 2032: | 4.05 USD Billion |
| Segments Covered: | by Product | Instruments Kits & Reagents Assays Services |
|
| by Technology | Polymerase Chain Reaction (PCR) Enzyme-Linked Immunosorbent Assay (ELISA) Culture-Based Methods DNA Staining Others |
||
| by Application | Cell Line Testing Virus Testing Production Others |
||
| by End User | Pharmaceutical & Biotechnology Companies Cell Banks & Laboratories Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs) Academic & Research Institutes Diagnostic Laboratories Hospitals Others |
||
Mycoplasma Testing Market, by Region:
• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• South America
Mycoplasma Testing Market Key Players:
• Thermo Fisher Scientific, Inc. (US)
• Charles River Laboratories International, Inc. (US)
• Lonza Group Ltd. (Switzerland)
• Merck KGaA (Germany)
• Roche Diagnostics (Switzerland)
• American Type Culture Collection (US)
• Bionique Testing Laboratories, Inc. (US)
• InvivoGen (US)
• PromoCell GmbH (Germany)
• Biological Industries Israel Beit Haemek Ltd. (Israel)
• Creative Bioarray (US)
• Mycoplasma Experience (UK)
• Norgen Biotek Corp. (Canada)
• Agilent Technologies (US)
• Biotools B & M Labs
• S.A. (Spain)
• Eurofins Scientific (Luxembourg)
• GeneCopoeia, Inc. (US)
• GenBio (Canada)
• Minerva Biolabs GmbH (Germany)
• Meridian Bioscience, Inc. (US)
• Sartorius AG (Germany)
• Savyon Diagnostics (Israel)
• Nelson Laboratories Fairfield, Inc. (US)
• Clongen Laboratories, Inc. (US)
• ScienCell Research Laboratories, Inc. (Canada)
Frequently Asked Questions:
1. Which region has the largest share in Global Mycoplasma Testing Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Mycoplasma Testing Market?
Ans: The Global Mycoplasma Testing Market is growing at a CAGR of 9% during forecasting period 2026-2032.
3. What is scope of the Global Mycoplasma Testing market report?
Ans: Global Mycoplasma Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Mycoplasma Testing market?
Ans: The important key players in the Global Mycoplasma Testing Market are Thermo Fisher Scientific, Inc. (US),Charles River Laboratories International, Inc. (US),Lonza Group Ltd. (Switzerland),Merck KGaA (Germany),Roche Diagnostics (Switzerland),American Type Culture Collection (US),Bionique Testing Laboratories, Inc. (US),InvivoGen (US),PromoCell GmbH (Germany),Biological Industries Israel Beit Haemek Ltd.
1.89